Probiotics in the application of inflammatory bowel disease        QIN Huan-long*，CHEN Hong-qi.  *Department of General Surgery, Shanghai Tenth People’s Hospital, Shanghai 200072, China
Corresponding author ：QIN Huan-long，E-mail：hlqin@sjtu.edu.cn
Abstract    Probiotic treatment of inflammatory bowel disease (IBD) has gradually become the hot issue in recent years. A growing number of experimental studies provide the important theoretical support for the application of probiotics in IBD, and achieved significant clinical effectiveness. Some probiotics have been recommended for maintenance of remission in mild to moderate UC patients and preventing and maintaining remission of pouchitis in UC patients pouch inflammation of postoperative UC patients. This paper will combine the latest results to evaluate the clinical efficacy in the treatment of UC, CD and postoperative patients with probiotics, and propose directions for future research, looking forward to more strictly large-scale clinical trials to further verify the efficacy and safety of probiotics in the treatment of IBD, and to guide clinical application of probiotics.